News for Precigen, Inc. (I5X.F)

Precigen, Inc. (NASDAQ:PGEN) Q4 2020 Earnings Conference Call Mar 01, 2020, 04:30 PM ET Company Participants Steven Harasym - Head, IR Helen Sabzevari - President & CEO Tom Samuelson -...

Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 31.25% and -16.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Shares of Precigen, Inc. (PGEN) slipped 7% on Friday morning after the company said it will raise $112.5 million from a public offering of 15 million common shares.

GERMANTOWN, Md., Jan. 22, 2021 /PRNewswire/ -- Precigen, Inc.? today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price... | January 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) ...

GERMANTOWN, Md., Jan. 21, 2021 /PRNewswire/ --?Precigen, Inc.? today announced it has commenced an underwritten public offering of shares of its common stock. In addition, Precigen... | January 21, 2021